drugset / Trial / NCT01433328

Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

NCT01433328 ↗

Phase 4 Terminated 4 enrolled Jewish General Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

Treprostinil subcutaneous (under the skin) infusion is a very good medication for treating pulmonary arterial hypertension but infusion site pain may be very severe in some patients. The investigators plan to treat patients receiving treprostinil with a subcutaneous infusion of lidocaine (a local anesthestic) to treat the pain.

Timeline

Start
2012-01
Primary completion
2012-03
Completion
2012-04

Outcome

Outcome not reported

Stopped: “Safety considerations”

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified — —